Masimo landed the European CE mark of approval for its new MightySat Rx pulse oximeter to be used in clinical environments. The device, which is available in three versions, features Masimo’s SET Measure-Through Motion and Low Perfusion technology that’s part of the company’s clinical oximeters already common in hospitals worldwide.
Using a tablet or smartphone clinicians can tap the data gathered by the Bluetooth-enabled MightySat Rx devices, displaying readings such as SpO2, pulse rate, and perfusion index obtained over a twelve hour period.
